India in talks to buy 50 million doses of Pfizer COVID-19 vaccine: Report
Indian health authorities are also in an advanced stage of negotiations with Johnson & Johnson, which has a deal with India-based Biological E. Ltd, to manufacture as many as 600 million doses, starting as soon as this month, the Journal reported.
Aug 11, 2021, 16:45 PM IST